Anti-ANPR-1 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibody raised against the carboxyterminal region of atrial natriuretic peptide receptor 1, validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential
UniProt
P16066
Size
100ug
Cat. #
RP1ANPR1

In stock

SKU
RP-ANPR1

Options

As low as: $130.00

Target Overview

Atrial natriuretic peptide receptor 1 (ANPR-1, also designated NPR1, NPR-A, or guanylate cyclase A; EC 4.6.1.2; UniProt P16066) is a single-pass transmembrane receptor that binds atrial natriuretic peptide (ANP/NPPA) and brain natriuretic peptide (BNP/NPPB), two vasoactive hormones central to cardiovascular homeostasis. Upon ligand binding, the intracellular guanylate cyclase domain catalyzes the conversion of GTP to cyclic GMP, which activates protein kinase G (PRKG1) and downstream effectors including PRKAA1. This signaling cascade regulates vascular tone, intravascular volume, and blood pressure. ANPR-1 is expressed predominantly in vascular endothelium, kidney, and adrenal gland, where it mediates natriuresis, diuresis, and vasodilation. The receptor plays an essential role in endothelial cell senescence and vascular aging. The 1061-amino acid protein features an extracellular ligand-binding domain, a single transmembrane helix, and a cytoplasmic region containing a kinase homology domain and the catalytic guanylate cyclase domain.

Background

ANPR-1 is a critical node in the natriuretic peptide system, which counterbalances the renin-angiotensin-aldosterone axis. Circulating ANP and BNP are released from cardiac myocytes in response to atrial stretch and ventricular wall stress, respectively. Binding to ANPR-1 triggers cGMP production, leading to smooth muscle relaxation, reduced sodium reabsorption in the kidney, and inhibition of aldosterone and renin secretion. Recent work has established that ANPR-1 activation controls endothelial senescence and vascular aging through cGMP-dependent kinase signaling, with loss of function associated with accelerated arterial stiffness and hypertension. Genetic variation in NPR1 has been linked to blood pressure regulation in human populations, and reduced receptor expression or desensitization contributes to hypertension and heart failure pathophysiology. The receptor undergoes ligand-induced internalization and dephosphorylation-dependent desensitization, providing feedback control of natriuretic peptide signaling. Therapeutic strategies targeting this pathway include recombinant natriuretic peptides and neprilysin inhibitors, which prevent degradation of endogenous ANP and BNP. ANPR-1 is also implicated in metabolic regulation, with cGMP signaling influencing adipocyte lipolysis and energy expenditure. While the majority of research focuses on mammalian cardiovascular biology, comparative studies have identified NPR1 orthologs in non-mammalian vertebrates, including fish, where the receptor exhibits functional divergence in osmoregulation and stress response. Triple Point Biologics offers two rabbit polyclonal antibodies (RP1ANPR1, RP2ANPR1) targeting the carboxyterminal region of human ANPR-1, validated for Western blot applications in human samples.

References

  1. Okinishi R et al (2026) Functional divergence of NPR1 paralog in the Japanese eel: Identification and neuroanatomical characterization. Gen Comp Endocrinol. PubMed · DOI

Additional Specifications

Size 100 µg
Gene Symbol NPR1
UniProt ID P16066
Host Species Rabbit
Species Reactivity Validated- Human
Potential
Pack Size 100ug
Immunogen (Carboxyterminal end Var 2)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 1011-1061.
Immunogen (Aminoterminal end short form)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 33-83.
Alternate Names NPR1, NPR-A, ANPR-A, ANP-A, Atrial natriuretic peptide receptor type A, Guanylate cyclase A, GC-A, EC 4.6.1.2

Frequently Asked Questions

What molecular weight band should I expect for ANPR-1 on Western blot?

ANPR-1 (NPR1/NPR-A) migrates at approximately 130 kDa on reducing SDS-PAGE, corresponding to the full-length single-pass transmembrane receptor. The protein contains an extracellular ligand-binding domain, a single transmembrane helix, and an intracellular guanylate cyclase catalytic domain. Post-translational glycosylation can shift the apparent molecular weight slightly higher than the predicted mass of 120 kDa. In some tissues, particularly kidney lysates, you may observe additional higher-molecular-weight species representing glycosylated or dimeric forms. We recommend including a positive control lysate from human kidney or adrenal tissue where ANPR-1 is abundantly expressed.

What starting dilution do you recommend for Western blot with this ANPR-1 antibody?

Start at 1:1000 dilution for Western blot, as validated in our hands with human tissue lysates. This rabbit polyclonal typically performs well in this range with standard chemiluminescent detection. If signal is weak in your sample type, you can titre up to 1:500. Conversely, if background is high, dilute to 1:2000. Optimal concentration depends on ANPR-1 expression level in your lysate; receptor abundance is highest in kidney medulla, adrenal cortex, and vascular endothelium. Use 5 percent non-fat milk or BSA in TBST for blocking and antibody dilution.

Is this antibody validated for detecting mouse or rat ANPR-1?

This antibody is validated only for human ANPR-1. Cross-reactivity with mouse (Npr1, UniProt P18910) or rat (Npr1, UniProt P18292) is predicted based on sequence homology—human and rodent ANPR-1 share approximately 85 percent identity across the extracellular and intracellular domains. We have not empirically tested reactivity in mouse or rat lysates, so if you are working with rodent samples, we recommend running a pilot experiment with appropriate positive controls such as mouse kidney lysate. Immunogen sequence alignment suggests conserved epitopes, but validation in your system is necessary.

Can I use this ANPR-1 antibody for immunohistochemistry or immunofluorescence?

Yes, this antibody is suitable for IHC and immunofluorescence in addition to Western blot. For IHC on formalin-fixed paraffin-embedded tissue, antigen retrieval is typically required; citrate buffer (pH 6.0) heat-induced epitope retrieval works well for many transmembrane receptors. Start with a 1:100 to 1:200 dilution and optimize based on signal and background in your tissue type. For IF, try 1:50 to 1:100 on fixed cultured cells or frozen sections. Kidney glomeruli and vascular endothelium are good positive-control tissues where ANPR-1 expression is robust and well-characterized.

What sample preparation works best for detecting ANPR-1 in tissue lysates?

ANPR-1 is a transmembrane protein, so use a lysis buffer containing detergent to solubilize membrane fractions effectively. RIPA buffer (with 1 percent NP-40 or Triton X-100, 0.5 percent sodium deoxycholate, 0.1 percent SDS) works well. Include protease and phosphatase inhibitors to preserve receptor integrity and phosphorylation states if you are studying signaling. For tissues rich in ANPR-1—kidney medulla, adrenal gland, or heart atrium—homogenize thoroughly and clarify lysates by centrifugation at 12,000 × g for 10 minutes. Load 20 to 40 micrograms total protein per lane for Western blot.

Does ANPR-1 have splice isoforms I need to account for?

The primary ANPR-1 transcript (NPR1 gene) encodes a 1061-amino-acid protein with no widely annotated functional splice variants in human. Minor splice events have been reported in the literature but are not well-characterized at the protein level. On Western blot, you should see a single predominant band near 130 kDa. If you observe multiple bands, consider the possibility of proteolytic cleavage, differential glycosylation, or cross-reactivity. ANPR-1 can undergo regulated proteolysis in some contexts, releasing extracellular or intracellular fragments, so sample handling and protease inhibition are important.

What are good positive and negative control tissues for ANPR-1 expression?

Positive controls: human kidney (especially medulla), adrenal gland, and vascular endothelium express high levels of ANPR-1. Heart atrial tissue is also positive. For cell lines, human umbilical vein endothelial cells (HUVEC) and some renal epithelial lines express detectable receptor. Negative controls are more challenging because ANPR-1 has broad low-level expression; however, many hematopoietic and lymphoid tissues show minimal expression. A validated negative control is lysate from cells transfected with empty vector alongside ANPR-1-overexpressing cells. Alternatively, compare signal in the presence of blocking peptide if available.

How should I store this antibody and what is the shelf life?

Store the antibody at –20°C as supplied. For routine use, you can aliquot the stock into single-use volumes to avoid repeated freeze-thaw cycles, which may reduce titre and increase aggregation over time. Once thawed, the antibody is stable at 4°C for up to one month when stored in the presence of carrier protein and preservative. Do not store diluted antibody in blocking buffer for more than a few days. Under proper storage at –20°C, polyclonal antibodies typically retain activity for at least two years from the date of manufacture.

Validation imagery coming soon

Western blot validation figures for RP-ANPR1 will be published here as they are produced in-house.

If you would like to see existing validation data for this antibody before publication, request a sample copy.

Also known as:

  • NPR1
  • NPR-A
  • ANPR-A
  • ANP-A
  • Atrial natriuretic peptide receptor type A
  • Guanylate cyclase A
  • GC-A
  • EC 4.6.1.2
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →